Publication | Closed Access

Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway

Tumor BiologyBreast OncologyMedicineCancer Cell Biologyβ-Catenin Signaling PathwayBreast CancerCancer BiologyRadiation OncologyOncologyCell BiologyCancer ResearchCancer Growth